Reduction of caveolin and caveolae in oncogenically transformed cells by Koleske, Anthony J. et al.
Proc. Natl. Acad. Sci. USA
Vol. 92, pp. 1381-1385, February 1995
Cell Biology
Reduction of caveolin and caveolae in oncogenically
transformed cells
(cancer/growth regulation/oncogene/potocytosis)
ANThoNY J. KOLESKE*, DAVID BALTIMORE*, AND MICHAEL P. LISANTIt
*Department of Biology, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139; and tWhitehead Institute for Biomedical
Research, 9 Cambridge Center, Cambridge, MA 02142
Contributed by David Baltimore, November 28, 1994
ABSTRACT Caveolae are flask-shaped non-clathrin-
coated invaginations of the plasma membrane. In addition to
the demonstrated roles for caveolae in potocytosis and trans-
cytosis, caveolae may regulate the transduction of signals
from the plasma membrane. Transformation ofNIH 3T3 cells
by various oncogenes- leads to reductions in cellular levels of
caveolin, a principal component of the protein coat of caveo-
lae. The reduction in caveolin correlates very well with the size
of colonies formed by these transformed cells when grown in
soft agar. Electron microscopy reveals that caveolae are mor-
phologically absent from these transformed cell lines. These
observations suggest that functional alterations in caveolae
may play a critical role in oncogenic transformation, perhaps
by disrupting contact inhibition in transformed cells.
Oncogenic transformation leads to many changes in cultured
cells. These changes include the loss of a requirement for
growth factors (1), alterations in cell-surface molecules and
membrane fluidity (2-4), the loss of contact inhibition of cell
division and motility (5, 6), and the loss of anchorage depen-
dence for growth (7). Measurements of these parameters are
used to evaluate the oncogenic potential of a gene or its mutant
derivatives. Despite the utility of these assays in scoring oncogenic
potential in vitro, the molecular mechanisms that regulate these
changes are poorly understood. A dissection of the molecular
mechanisms behind these changes should lead to enhanced un-
derstanding of tumor initiation and progression in vivo.
Caveolae are 50- to 100-nm flask-shaped invaginations of
the plasma membrane (8, 9). Caveolae have been implicated in
potocytosis and transcytosis of small molecules and ions in
endothelial cells and sorting of surface proteins in polarized
epithelial cells (8, 10-13). Several lines of evidence suggest that
caveolae may also participate in signal transduction. For ex-
ample, caveolin, a protein found on the inner striated coat of
caveolae, is a major v-src substrate in Rous sarcoma virus-
transformed chicken embryo fibroblasts (14, 15). Both the
phosphorylation of caveolin and transformation are depen-
dent on the myristoylation of v-src (16). Furthermore, several
G-protein-coupled receptors and bacterial toxins that modify
G proteins are localized to or internalized by caveolae (for
review, see ref. 17). Glycosyl-phosphtidylinositol (GPI)-linked
proteins and the muscarinic acetylcholine receptor cluster to
caveolae in response to cross-linking antibodies or receptor
agonists, respectively (18, 19). Finally, purified caveolar mem-
brane domains are enriched in signaling proteins: Src-like
nonreceptor tyrosine kinases, heterotrimeric G proteins, the
ras-related GTPase Rap 1A, mitogen-activated protein ki-
nases, other serine/threonine kinases, SH2-SH3 adaptor pro-
teins, and other proteins with roles in signal transduction
(20-22).
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Caveolae may regulate the proliferation of normal cells in
vitro. We have recently observed that NIH 3T3 cell lines
transformed by several different oncogenes express greatly
reduced levels of caveolin. Furthermore, the reduction of
caveolin in these cell lines correlates with the size of colonies
they form upon growth in soft agar. Electron microscopy
reveals that caveolae are missing from the transformed cells
that express reduced levels of caveolin. The reduction in caveo-
lin does not correlate with serum requirements for growth of
these cell lines in culture. The loss of caveolin could contribute
to a loss of contact inhibition of motility or mitosis in trans-
formed cells that may be critical to allow cells to proliferate in
soft agar.
MATERIALS AND METHODS
Cell Culture. Normal and transformed NIH 3T3 cell lines
were cultured on 90- or 150-mm tissue culture plates in Dul-
becco's modified Eagle's medium (DMEM) containing 10%
(vol/vol) donor calf serum (DCS) (GIBCO). The v-abl, poly-
oma virus middle-sized tumor antigen (mTAg)-, bcr-abl
(p210)-, and crkl-transformed NIH 3T3 cell lines were the gifts
ofWarren Pear, Ruibao Ren, and Martin Scott (Massachusetts
Institute of Technology). The H-rasGl2V-transformed cell line
was the gift of David Sanders (Whitehead Institute). The
v-src-transformed NIH 3T3 cell line was the gift of David
Shalloway (Cornell University, Ithaca, NY). To assay serum
requirements for growth and survival, 1000 cells of each cell
line were plated onto multiple 60-mm plates in DMEM con-
taining 10% DCS. The medium was replaced the following day
with DMEM containing 10%, 5%, 2%, or 0.5% DCS. Cells
were fed every 3 days. After 10 days, colonies arising from the
plated cells were visualized by staining with 0.1% crystal violet
in 50% (vol/vol) MeOH. Colony numbers were normalized to
numbers observed on plates grown in 10% DCS. To assay
growth in soft agar, 1000 cells of each line were suspended in
3 ml of DMEM containing 5% and 10% DCS and 0.33%
SeaPlaque low-melting-temperature agarose (American Bio-
analytical, Natick, MA). These cells were plated over a 2-ml
layer of solidified DMEM containing 5% or 10% DCS and
0.5% agarose, and cells were allowed to settle to the interface
between these layers at 37°C. After 20 min, plates were allowed
to harden at room temperature for 30 min before returning to
37°C. The plates were fed every 3-4 days by overlaying with 2
ml of medium containing 0.33% agarose. After 2 weeks, the
plates were stained with 0.1% crystal violet in 50% MeOH at
4°C. Plates were destained with cold water. Colonies were
photographed under low (X4) magnification.
Western Blot Analysis. Cells were disrupted in RIPA buffer
(20 mM Mes, pH 6.5/150 mM NaCl/1% Triton X-100/0.1%
SDS/1 mM phenylmethylsulfonyl fluoride/2mM benzamidine
hydrochloride). Protein was quantitated with Bio-Rad protein
Abbreviations: DCS, donor calf serum; mTAg, middle-sized tumor
antigen.
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assay kit and bovine serum albumin as a standard. Blots were
prepared by standard procedures (23). Blots were probed with
anti-caveolin monoclonal antibodies (Transduction Laborato-
ries, Lexington, KY) or anti-Hsp7O polyclonal antiserum (a gift
of Peter Murray, Whitehead Institute). The proteins were
visualized with horseradish peroxidase-conjugated secondary
antibodies and the ECL system (Amersham). Amounts of
caveolin in transformed cells were determined by comparison
to standard dilutions of NIH 3T3 cell extract.
Northern Blot Analysis. Total RNA was extracted with
TriReagent LS (Molecular Research Center, Cincinnati) by
the manufacturer's instructions. Fifteen micrograms of total
cellular RNA was denatured with glyoxal and subjected to
Northern blot analysis with 32P-labeled probes for the mouse
caveolin mRNA (2.4 kb) and human 28S RNA (a gift of Pat
Guilfoile, Whitehead Institute), as a control for loading.
Transmission Electron Microscopy. Cells were fixed with
glutaraldehyde, postfixed with OS04, and stained with uranyl
acetate and lead citrate as described (20). Samples were ex-
amined under the Philips 410 transmission electron microscope.
Cells were photographed at a magnification of x 115,500. Caveo-
lae were identified by their characteristic flask shape, size (50-100
nm), and location at or near the plasma membrane.
RESULTS
Caveolin Is Reduced in Transformed NIH 3T3 Cell Lines.
Caveolin, a principal component of the protein coat of caveo-
lae, is phosphorylated on tyrosine in v-src-transformed fibro-
blasts, suggesting a relationship between alterations in the
structural components of caveolae and oncogenic transforma-
tion (14-16). To determine whether alterations of caveolin
structure or function occur during transformation by onco-
genes other than v-src, the caveolin in extracts of oncogenically
transformed NIH 3T3 cell lines was compared to caveolin in
extracts of normal NIH 3T3 cell lines. The amount of caveolin
in normal or transformed NIH 3T3 cell lines was assayed by
Western blot analysis (Fig. 1A). The level of caveolin was
clearly reduced in NIH 3T3 cell lines transformed by expres-
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FIG. 1. Caveolin expression in normal and transformed NIH 3T3
cell lines. (A) Protein (50 ,g) from wild-type NIH 3T3 cells or NIH
3T3 cell lines transformed with v-abl (v-abl), p2l0bcr-abl (bcr-abl),
polyoma virus mTAg (middle T), H-rasG12V (ras), or crkl (HA-crkl)
was subjected to Western blot analysis with antibodies to caveolin or,
as a control, cytosolic Hsp70. The proteins were visualized with
horseradish peroxidase-conjugated secondary antibodies and the ECL
system. (B) Total cellular RNA (15 ,ug) was denatured with glyoxal and
subjected to Northern blot analysis with 32P-labeled probes for caveo-
lin mRNA (2.4 kb) and 28S RNA, as a control.
sion of the v-abl, bcr-abl,H-rasG12V, polyoma virus mTAg, or
crkl oncogenes. The relative amount of caveolin in the trans-
formed cells was estimated by Western blot analysis with
dilutions of NIH 3T3 protein extract as a standard (data not
shown). Similar analysis was performed for the cytosolic heat
shock protein Hsp7O as a control for loading. The amount of
caveolin in transformed cells varied from about 30% of levels
found in normal NIH 3T3 cells (in crkl-transformed cells) to
less than 1% of normal levels (in v-abl-transformed cells) (see
Fig. 2).
Northern blot analysis of total cellular RNA revealed that
caveolin mRNA was reduced in the transformed NIH 3T3 cell
lines in parallel with the amount of caveolin protein found in
these cell lines (Fig. 1B). In the one noteworthy exception,
there appeared to be a slight induction of caveolin mRNA in
the NIH 3T3 cell line transformed by expression of polyoma
mTAg. Western blot analysis revealed that these cells had only
4% the level of caveolin found in normal NIH 3T3 cells,
suggesting that caveolin is either less stable or translated at a
reduce-d rate in these cells. Identical results were obtained by
S1 nuclease analysis with an oligonucleotide complementary
to caveolin mRNA (data not shown).
Correlation with the Size of Colonies in Soft Agar. Onco-
genically transformed cells are often able to grow under con-
ditions that limit growth of normal cells. The normal or trans-
formed NIH 3T3 cell lines analyzed above were assayed for
growth under restrictive conditions to gain insight into possible
roles of caveolin in regulating cell growth. When plated in soft
agar, normal cells will cease division whereas transformed cells
will continue to proliferate. The NIH 3T3 cell lines were plated
at low density in soft agar and incubated for 2 weeks. Although
the transformed cell lines formed colonies in soft agar with
similar efficiencies (70-100%), the sizes of the colonies
formed by these cell lines varied widely. Interestingly, the size
of colonies formed by these cell lines in soft agar correlated
very well with the reduction of caveolin (Fig. 2). For example,
the v-abl-transformed cell line, which contained the least
caveolin among those transformed lines examined, formed the
largest colonies when grown in soft agar. Conversely, colonies
formed by the crkl-transformed cell line are very small and
these cells exhibited a less dramatic reduction in caveolin.
Transformed cells often exhibit a decreased requirement for
growth factors for cell survival and proliferation. The NIH 3T3
cell lines were plated at low density on 60-mm plates. After
incubation in medium containing 10% DCS serum for 1 day,
the cells were incubated in medium containing 10%, 5%, 2%,
or 0.5% DCS. After 10 days, the number of colonies arising on
the plates was quantitated after staining with crystal violet
(Fig. 3). Each cell line exhibited different survival and growth
properties under conditions of reduced serum. Surprisingly,
while two transformed cell lines (bcr-abl, HA-crkl) grew much
better than normal NIH 3T3 cells, the other lines appeared to
grow slightly worse than normal NIH 3T3 cells in conditions
of reduced serum. Clearly, there is no correlation between the
levels of caveolin and a decreased requirement for serum.
Transformed Cells Contain No Detectable Caveolae. Caveo-
lae can be readily visualized in a wide range of endothelial and
epithelial cells by transmission electron microscopy (14). Nor-
mal, v-abl-transformed, and H-rasGl2V-transformed NIH 3T3
cells were fixed, stained, and analyzed by transmission electron
microscopy. Caveolae are abundant in normal NIH 3T3 cells
and can be distinguished by their characteristic size (50-100
nm), flask-like shape, and location on, or juxtaposition to, the
plasma membrane (Fig. 4A). Every field of sectioned NIH 3T3
cells examined in this way contained at least 5-10 caveolae and
in many cases dozens of clustered caveolae could be found. In
contrast, v-abl- and H-rasG12V_transformed cells contained few
if any detectable caveolae (Fig. 4 B and C). Despite viewing
>20 fields of each of these cells, only one structure resembling
a caveola was observed in the v-abl-transformed cells. Thus,
1382 Cell Biology: Koleske et al.
Proc. Natl. Acad ScL USA 92 (1995) 1383
120-Amount of caveolin
(% wild type)
<1%
2%
4%
4%
30%
100%
100
v-abl
80
*- 60-
bcr-abl
40
20
ras
middle T
HA-crkl
NIH3T3
FIG. 2. Growth of normal and transformed NIH 3T3 cell lines in
soft agar. Cell lines as described in Fig. 1 were plated at a density of
1000 cells per 60-mm dish in growth medium (DMEM) containing
10% DCS and 0.33% soft agar. Cells were fed twice weekly and were
stained after 2 weeks with 0.1% crystal violet in 50% MeOH. Plates
were destained and photographed under low magnification (x 10).
The amount of caveolin in each cell line was quantitated by Western
blot analysis as in Fig. 1 with dilutions of NIH 3T3 protein extract as
a standard (data not shown). Similar results were obtained with cells
grown in DMEM containing 5% DCS. (X4.)
two transformed cell lines that contain reduced levels of caveo-
lin also contain few caveolae.
DISCUSSION
The disruption of caveolar integrity appears to be a general
feature of oncogenic transformation of fibroblasts. Although
the v-abl, bcr-abl, H-rasGl2V, mTAg, and crkl oncogenes ini-
tiate transformation by different mechanisms (24), cellular
transformation by each of these proteins leads to reductions in
cellular levels of caveolin. It is unclear whether the reduction
*in caveolin levels is a direct result of an oncogenic stimulus or,
rather, whether cells that express reduced levels of caveolin are
preferentially selected for oncogenic transformation. These
reductions in caveolin probably contribute to a loss of caveolae
as observed in cells transformed by v-abl and H-rasGl2V. It is
unclear, however, whether the loss of caveolae is solely due to
reductions in caveolin levels. Future experimentation should
indicate whether the loss of caveolin leads to a loss of caveolae.
More importantly, these experiments should also determine
whether the loss of caveolar integrity is necessary or sufficient
for cellular transformation.
Three pathways exist to alter caveolin or reduce caveolin
levels in transformed cells. In v-src-transformed chicken em-
bryo fibroblasts, caveolin is phosphorylated on tyrosine resi-
dues, although the functional consequences of this modifica-
tion are not understood (15, 16). In the course of this study, we
also observed phosphorylation of caveolin in v-src-trans-
formed NIH 3T3 cells (data not shown). In v-abl-, bcr-abl-,
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FIG. 3. Serum requirements of normal and transformed NIH 3T3
cell lines in soft agar. Cell lines as described in Fig. 1 were plated at
a density of 1000 cells per 60-mm dish in growth medium (DMEM)
containing 10% DCS. The medium was replaced the following day
with DMEM containing 10%, 5%, 2%, or 0.5% DCS. Cells were fed
every 3 days. After 10 days, colonies arising from the plated cells were
visualized by staining with 0.1% crystal violet in 50% MeOH. Colonies
were counted and normalized (as a percentage) to the number of
colonies that grew on plates in medium containing 10% DCS (100%).
The number of colonies surviving is an average from two plates. The
number of surviving colonies are plotted as a function of serum
concentration.
H-rasG12V-, and crkl-transformed cells, reductions in steady-
state levels of caveolin mRNA lead to the reduction in caveolin
levels. Transformation by mTAg leads to reductions in caveo-
lin protein to 4% of levels in normal cells without a parallel
reduction in caveolin mRNA levels. These data imply another
pathway that regulates the synthesis or stability of caveolin.
The existence of multiple mechanisms that alter caveolin levels
and/or structure suggests that caveolin may be a critical target
in the pathway leading to cellular transformation.
A classic in vitro criterion of cellular transformation is the
ability to grow in soft agar. It was therefore very striking that
caveolin levels correlated with this parameter, suggesting there
might be a causal relationship between caveolin levels and growth
in soft agar. Despite this correlation, caveolin levels have no
relationship to the serum requirements for growth of normal or
transformed cells in culture. These data implicate caveolae spe-
cifically in the regulation of cell growth in soft agar.
How might caveolin regulate the ability of cells to grow in
soft agar? In normal cells, both motility and mitosis are in-
hibited by contact with other cells (5, 6). A loss of inhibition
of either of these processes may allow transformed cells to
grow in soft agar. Although caveolin is distributed throughout
the cell surface, it is concentrated on the leading edge of cells
(14). Interestingly, contact between a cell's leading edge and
adjacent cells mediates contact inhibition of movement and
may also play a role in inhibiting proliferation (6). A reduc-
tion of caveolae in the leading edge of cancer cells may thus
render them insensitive to contact inhibition of growth or
motility.
Several observations are also consistent with a direct role for
caveolae in the transduction of signals from the plasma mem-
brane. Caveolar membrane domains are enriched in proteins
with roles in signal transduction (20-22). Interestingly, the
muscarinic acetylcholine receptor is clustered into caveolae
upon treatment with agonists but not with antagonists (18).
Similarly, antibody crosslinking of glycosyl-phosphatidylinosi-
tol (GPI)-linked proteins leads to their clustering in caveolae
(19). Treatment of cells with activators of protein kinase C
cause caveolae to flatten out, demonstrating a link between
intracellular signaling and the structural integrity of caveolae
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FIG. 4. Electron microscopy of normal and transformed NIH 3T3 cells. Cells were fixed with glutaraldehyde, postfixed with OS04, and stained
with uranyl acetate and lead citrate. Cells were photographed at a magnification of X104,000. Caveolae were located by their characteristic
flask-shape, size (50-100 nm), and location at or near the plasma membrane. Caveolae are indicated by arrows. (Bar = "50 nm.) (A) NIH 3T3
cell. (B) H-rasGl2V-transformed NIH 3T3 cell. (C) v-abl-transformed NIH 3T3 cell.
(25). These observations seem to implicate caveolae in the
potentiation of signals from the plasma membrane. However,
these observations are also consistent with a role for caveolae
in sequestering signaling molecules to attenuate signaling after
receptor stimulation. The reduction of caveolae in trans-
formed cells could prevent the downregulation of growth-
promoting signals, thus contributing to uncontrolled prolifer-
ation.
Proc. NatL Acad ScL USA 92 (1995)
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Several proteins that mediate the internalization of extra-
cellular or membrane-associated molecules are phosphory-
lated on tyrosine in Rous sarcoma virus-transformed cells: the
gap junction protein connexin 43, the heavy chain of clathrin,
and caveolin. Interestingly, the phosphorylation ofconnexin 43
by v-src has been correlated to a decrease in junctional per-
meability inXenopus oocytes (26). Similarly, oncogenic stimuli
may downregulate clathrin-coated pits and caveolae to limit
the receptor-mediated and potocytotic uptake of small solutes
and molecules. These modifications may insulate the cancer
cell from molecules and signals that may be toxic or inhibitory
to rapidly dividing cells.
These studies demonstrate a general reduction of caveolin
and caveolae in fibroblasts transformed by various oncogenes.
However, these studies do not show that caveolae directly
modulate the oncogenic program in transformed cells. The
inverse correlation between cellular caveolin levels and the
ability to grow in soft agar does suggest that caveolae may
directly regulate the ability of cells to grow in soft agar.
Note Added in Proof. Recent experiments show that in NIH 3T3 cells
transformed by a temperature-sensitive Abelson virus, caveolin levels
are increased by shift to the nonpermissive temperature. Thus, caveo-
lin levels appear to be directly regulated by an oncogenic stimulus.
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